Endpoint definition
↥Filter registries None
Check pre-conditions None
Include endpoints
Check conditions None
Apply sex-specific rule None
Extra metadata
interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Filter registries None
Check pre-conditions None
Include endpoints
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Interstitial lung disease endpoints based on the number of shared cases.
Broader endpoints:
None
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 27356 | 16289 | 11067 |
Unadjusted prevalence (%) | 10.52 | 11.08 | 9.79 |
Mean age at first event (years) | 47.13 | 45.61 | 49.37 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.03 | 2.41 [2.15, 2.70] | 5.8e-52 | 2781 |
15 years | 0.02 | 2.86 [2.60, 3.15] | <1e-100 | 2266 |
5 years | 0.01 | 4.69 [4.24, 5.20] | <1e-100 | 1032 |
1 year | 0.00 | 8.55 [7.31, 10.00] | <1e-100 | 367 |
Index endpoint: ILD_ENDPOINTS – Interstitial lung disease endpoints
GWS hits: 27
before Interstitial lung disease endpoints
after Interstitial lung disease endpoints
Loading survival analyses plot
Loading survival analyses table